![](https://d3ilqtpdwi981i.cloudfront.net/_Fm_e2AyyjsHZ-AFpCqtxq_6Wdw=/0x39:371x519/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/4c/e3/6f/4ce36f93-6b3f-456a-88cb-cd0c9a8bf1c5/BHSF%20Pineapple%20Logo%20%28Imported%20Works%29.png)
Presentation
Resection rate of locally advanced pancreatic cancer in gemcitabine plus nab-paclitaxel versus FOLFIRINOX.
Journal of Clinical Oncology
(2021)
Disciplines
Publication Date
January 22, 2021
DOI
10.1200/JCO.2021.39.3_SUPPL.381
Citation Information
Shahriar Sharif, Amer H. Zureikat, Paula M. Novelli, Charles D. Lopez, et al.. "Resection rate of locally advanced pancreatic cancer in gemcitabine plus nab-paclitaxel versus FOLFIRINOX." Journal of Clinical Oncology (2021) Available at: http://works.bepress.com/antonio-ucar/29/